Analytical Data
-
基因名
FGFR-2
- Application
-
生物活性
Measured by its ability to inhibit FGF-acidic dependent proliferation of Balb/c 3T3 mouse fibroblasts. The ED50 for this effect is 1.667 ng/mL, corresponding to a specific activity is 6.0×105 units/mg. Measured by its ability to inhibit FGF-acidic dependent proliferation of Balb/c 3T3 mouse fibroblasts. The ED50 for this effect is 1.667 ng/mL, corresponding to a specific activity is 6.0×105 units/mg.
-
别名
Fibroblast growth factor receptor 2; FGFR-2; KSAM; KGFR; CD332; BEK
-
种属
Mouse
-
表达系统
HEK293
-
标签
C-6*His
-
纯度
Greater than 95% as determined by reducing SDS-PAGE.
-
蛋白编号
E9Q5C3
-
表达区间
R22-E263
-
氨基酸序列
RPSFSLVEDTTLEPEGAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPTPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCLVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKHSGINSSNAEVLALFNVTEMDAGEYICKVSNYIGQANQSAWLTVLPKQQAPVREKEITASPDYLE
-
蛋白长度
Partial
-
分子量
40-7 kDa.
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Related Products
Protein Description
Fibroblast Growth Factor Receptor 2 (FGFR-2) is a critical member of the FGFR family, which plays a vital role in various physiological processes, including cell proliferation, differentiation, and tissue repair. Abnormal FGFR-2 signaling has been implicated in several diseases, particularly various forms of cancer and congenital disorders. The understanding of FGFR-2 functions has spurred significant interest in its potential as a therapeutic target. Research has shown that FGFR-2 is involved in pathways that regulate angiogenesis and epithelial-mesenchymal transition, making it a significant player in tumor progression and metastasis. The development of FGFR-2 recombinant proteins has become a focus in biomedical research, facilitating the study of receptor interactions, signaling mechanisms, and the evaluation of potential inhibitors. Recombinant FGFR-2 proteins serve as valuable tools for drug discovery and the development of targeted therapies, allowing for the exploration of FGFR-2's role in disease mechanisms. As researchers continue to unveil the complexities of FGFR-2 signaling, the insights gained may lead to innovative treatments and improved clinical outcomes for patients suffering from FGFR-2-related pathologies.
